2,5-Dimethoxy-4-iodoamphetamine (DOI) Inhibits Δ9-Tetrahydrocannabinol-Induced Catalepsy-Like Immobilization in Mice

1 Fujiwara M, Egashira N. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB₁ cannabinoid receptor and development of therapeutic application. J Pharmacol Sci. 2004;96:362–366.

2 Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Δ⁹-tetrahydrocannabinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther. 2005;314:329–337.

3 Egashira N, Matsuda T, Koushi, E, Mishima K, Iwasaki K, Shoyama Y, et al. Involvement of 5-hydroxytryptamine_1A receptors in Δ⁹-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Eur J Pharmacol. 2006;550:117–122.

4 Anderson JJ, Kask AM, Chase TN. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur J Pharmacol. 1996;295:163–168.

5 Marchese G, Casti P, Ruiu S, Saba P, Sanna A, Casu G, et al. Haloperidol, but not clozapine, produces dramatic catalepsy in Δ⁹-THC-treated rats: possible clinical implications. Br J Pharmacol. 2003;140:520–526.

6 Pires JG, Bonikovski V, Futuro-Neto HA. Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Braz J Med Biol Res. 2005;38:1867–1872.

7 Hicks PB. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 1990;47:1609–1615.

8 Invernizzi RW, Cervo L, Samanin R. 8-Hydroxy-2-(di-<i>n</i>-propylamino) tetralin, a selective serotonin_1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology. 1988;27:515&ndash;518.

9 Lucas G, Bonhomme N, De Deurwaerd&egrave;re P, Le Moal M, Spampinato U. 8-OH-DPAT, a 5-HT_1A agonist and ritanserin, a 5-HT_2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology. 1997;131:57&ndash;63.

10 Neal-Beliveau BS, Joyce JN, Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther. 1993;265:207&ndash;217.

11 Wadenberg ML, Ahlenius S. Antagonism by the 5-HT_2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat. Eur J Pharmacol. 1995;294:247&ndash;251.

12 Bartoszyk GD, Roos C, Ziegler H. 5-HT_1A receptors are not involved in clozapine&rsquo;s lack of cataleptogenic potential. Neuropharmacology. 1996;35:1645&ndash;1646.

13 Egashira N, Mishima K, Katsurabayashi S, Yoshitake T, Matsumoto Y, Ishida J, et al. Involvement of 5-hydroxytryptamine neuronal system in &Delta;⁹-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol. 2002;445:221&ndash;229.

15 Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, et al. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology. 2004;171:382&ndash;389.

16 Egashira N, Tanoue A, Higashihara F, Fuchigami H, Sano K, Mishima K, et al. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology. 2005;30:1996&ndash;2005.

18 Herkenham M, Lynn AB, Johnson MR, Melvin LS, De Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991;11:563&ndash;583.

19 Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB₁ receptors in the rat central nervous system. Neuroscience. 1998;83:393&ndash;411.

21 Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. serotonin-2 receptors. Brain Res. 1985;346:231&ndash;249.

22 Hoffman AF, Lupica CR. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol. 2001;85:72&ndash;83.

23 Manzoni OJ, Bockaert J. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur J Pharmacol. 2001;412:R3&ndash;R5.

24 Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci. 2001;21:109&ndash;116.

25 Yan QS, Reith ME, Jobe PC, Dailey JW. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 1997;765:149&ndash;158.

26 Kinoshita H, Hasegawa T, Katsumata Y, Kameyama T, Yamamoto I, Nabeshima T. Effect of dizocilpine (MK-801) on the catalepsy induced by &Delta;⁹-tetrahydrocannabinol in mice. J Neural Transm Gen Sect. 1994;95:137&ndash;143.

27 Pertwee RG, Greentree SG, Swift PA. Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with &Delta;⁹-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology. 1988;27:1265&ndash;1270.

28 Marchese G, Casti P, Ruiu S, Saba P, Sanna A, Casu G, et al. Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications. Br J Pharmacol. 2003;140:520&ndash;526.

29 Fletcher PJ, Sinyard J, Higgins GA. The effects of the 5-HT_2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl). 2006;187:515&ndash;525.